- Asymptomatic bacteriuria → do not treat (except pregnancy and before urologic procedures with mucosal injury). Cloudy/smelly urine ≠ UTI.
- IDSA 2025: infection confined to the bladder (afebrile) = uncomplicated in women and men. Infection beyond the bladder (fever, flank pain, bacteremia, CAUTI with systemic signs, prostatitis) = complicated.
- cUTI empiric (no sepsis): 3rd/4th-gen cephalosporin, pip-tazo or FQ. Sepsis: broaden (carbapenem if ESBL risk).
- Switch to oral when improving. Duration 7 days (5–7 for FQ), also with gram-negative bacteremia if improving.
- Obstruction (stone) + infection = urology now (decompression).
Pathophysiology in 60 seconds
⌄
- Gut flora (E. coli ~75%) colonize the periurethral area → ascend to bladder → kidneys.
- Risk: female anatomy, sex, catheters, obstruction (stones, BPH), diabetes, pregnancy, urinary retention.
- Catheters grow a biofilm in days → bacteriuria is almost universal by 30 days → culture only if symptoms.
Diagnosis
⌄
| Picture | Definition |
|---|---|
| Cystitis | Dysuria, frequency, urgency, suprapubic pain — no fever |
| Complicated UTI | Fever, chills, flank pain/CVA tenderness, rigors, bacteremia, sepsis, delirium with no other source |
| CAUTI | Catheter (or removed ≤48 h) + symptoms + ≥10³ CFU/mL; no other source |
| ASB | ≥10⁵ CFU/mL, no symptoms |
- UA + culture before antibiotics. Pyuria supports but does not prove UTI; no pyuria → UTI unlikely.
- Blood cultures if febrile/septic.
- Imaging (CT or US) if sepsis, no improvement in 48–72 h, stone history, or suspected abscess/obstruction.
- Confused older patient without urinary symptoms or fever → look for other causes first.
Management
⌄
| Drug | Course |
|---|---|
| Nitrofurantoin 100 mg BID | 5 days (not if CrCl <30 or suspected pyelo) |
| TMP-SMX DS BID | 3 days (if resistance <20%) |
| Fosfomycin 3 g | Single dose |
| Cephalexin / cefpodoxime | 5–7 days |
Men with afebrile cystitis: same drugs; often 7 days.
- Empiric: ceftriaxone 1–2 g daily, cefepime, pip-tazo, or FQ. Avoid drugs that failed before (prior resistant isolate).
- Sepsis or ESBL risk → meropenem/ertapenem.
- Narrow to culture results.
- IV → PO when improving (e.g., FQ, TMP-SMX, oral β-lactam with high dose).
- Duration: 7 days (FQ 5–7 days). Longer for abscess, prostatitis, slow response, undrained obstruction.
- Remove or replace the catheter (if in >2 weeks), then culture from the new catheter.
- 7 days if prompt response; 10–14 if delayed.
- Prevention: avoid catheters; remove daily review; bladder scan protocols.
Pitfalls
⌄
- Treating a positive culture in a delirious patient with no urinary symptoms or fever — then missing pneumonia.
- Nitrofurantoin for pyelonephritis (poor tissue levels).
- 14 days of IV ceftriaxone for a simple pyelo.
- Missing an obstructed infected kidney — needs drainage, not just antibiotics.
Board corner
⌄
| Stem | Answer |
|---|---|
| Nursing home, no symptoms, culture >10⁵ | Do not treat |
| Pregnant, ASB | Treat (cephalexin, nitrofurantoin) |
| Fever, flank pain, obstructing stone on CT | Antibiotics + urgent decompression (stent/nephrostomy) |
| Man, dysuria, afebrile | Cystitis — uncomplicated under IDSA 2025 |
| Pyelo, improving on ceftriaxone, cultures sensitive | Oral switch, 7 days total |
References
⌄
- Trautner BW, et al. 2025 IDSA Guideline on Management of Complicated UTI. Clin Infect Dis. 2025.
- Nicolle LE, et al. 2019 IDSA Guideline for Asymptomatic Bacteriuria. Clin Infect Dis. 2019;68:e83.
- Hooton TM, et al. IDSA CAUTI guideline. Clin Infect Dis. 2010;50:625.